Allure Magazine Honors Arcutis’ ZORYVE® (roflumilast) with Prestigious Best of Beauty Breakthrough Award

ZORYVE Allure Best of Beauty Product Image Allure Best of Beauty Breakthrough Award Winner ZORYVE (roflumilast) cream 0.15%; ZORYVE (roflumilast) topical foam 0.3%; ZORYVE (roflumilast) cream 0.3% Allure Best of Beauty Award Seal 2025 Allure Best of Beauty Award Seal 2025 First FDA-approved medication for atopic dermatitis (eczema), plaque psoriasis, and seborrheic dermatitis to win prominent “Breakthrough Award”ZORYVE is the number one prescribed branded topical therapy across three major inflammat ...